Download - WHOCC
Download - WHOCC
Download - WHOCC
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
QL<br />
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS<br />
The group QL comprises preparations, e.g. alkylating agents, antimetabolites, plant<br />
alkaloids and cytotoxic antibiotics, used in the treatment of malignant neoplastic<br />
diseases. Immunomodulating agents, both stimulating and suppressive agents, are<br />
also classified here.<br />
Hormonal preparations specifically used in the treatment of neoplastic diseases<br />
should be classified in this group. Note that group QG03 - Sex hormones and<br />
modulators of the genital system might include the same hormone, but of a different<br />
strength. Gonadotropin-releasing hormone (GnRH) and analogues not used for<br />
endocrine therapy related to neoplastic diseases are classified in QH01CA -<br />
Gonadotropin-releasing hormones.<br />
QL01<br />
ANTINEOPLASTIC AGENTS<br />
Combination preparations are classified in QL01XY. Detoxifying agents used in<br />
connection with high-dose treatment with antineoplastic agents are classified in<br />
QV03AF - Detoxifying agents for antineoplastic treatment.<br />
QL01A<br />
QL01AA<br />
QL01AB<br />
QL01AC<br />
QL01AD<br />
QL01AG<br />
QL01AX<br />
ALKYLATING AGENTS<br />
Nitrogen mustard analogues<br />
Alkyl sulphonates<br />
Ethylene imines<br />
Nitrosoureas<br />
Epoxides<br />
Other alkylating agents<br />
QL01B<br />
QL01BA<br />
ANTIMETABOLITES<br />
Folic acid analogues<br />
Methotrexate in oral formulations is classified in QL04AX.<br />
QL01BB<br />
QL01BC<br />
Purine analogues<br />
Pyrimidine analogues<br />
128
Change language